KZA — Kazia Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$18.24m
- AU$14.80m
- AU$0.02m
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia Appendix 4G
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 08:31:10
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia Appendix 4E
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia corporate presentation
Brief: Kazia Therapeutics Provides Progress Update On Paxalisib And Evt801 Clinical Programs
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia update
Australia's Kazia rises on U.S., India patents for brain tumour inhibitor
Brief: Kazia Therapeutics Says Manufacturing Patents Granted For Paxalisib
Australia Stock Exchange release from KAZIA THERAPEUTI : Manufacturing patents granted for paxalisib
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:38:17
Australia Stock Exchange release from KAZIA THERAPEUTI : Ceasing to be a substantial holder
Brief: Kazia Enters Clinical Collaboration With Cornell University
Australia's Kazia Therapeutics jumps as study begins for brain tumour medication
Brief: Kazia Therapeutics Launches New Paxalisib Phase Ii Clinical Trial
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia launches new paxalisib phase II clinical trial
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:19:53
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:22 PM
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia paxilisib in Dana Farber study enrols first patient
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:51:28